Treatment
-
Genetic Testing for Women With Breast CancerNew recommendations clarify when women diagnosed with breast cancer should be offered genetic testing for inherited cancer risk.
by Laura Gesualdi-Gilmore
-
TIL Therapy Amplifies the Immune System’s Attack on MelanomaThe recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
-
Facts and Stats
Breast Cancer Survival Rates Continue to RiseNew report highlights decades of progress, as well as a persisting disparity.
by Thomas Celona
-
Taking a Shot Against Cancer RecurrencesEarly findings on therapeutic vaccines suggest they can delay or stop cancer from returning after tumors are surgically removed.
by Kendall K. Morgan
-
Forward Look
Preventing Blood ClotsMedical oncologist Michael B. Streiff discusses new guidelines to reduce the risk of life-threatening blood clots.
by Ashley P. Taylor
-
Forward Look
Non-surgical Options in Bladder CancerSome people with muscle-invasive cancer can forgo bladder removal surgery.
by Darcy Lewis
-
CAR T-cell Therapy: Understanding the Warning and the RisksThe FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
-
Emerging Treatments for Brain Metastases in Breast CancerSABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
by Marci A. Landsmann
-
From the Editor-in-Chief
Cancer Treatment: Can Less Be More?Molecular profiling that has led to spectacular advances in cancer treatment may also improve cancer survivorship.
by William G. Nelson, MD, PhD
-
Forward Look
CDK4/6 Inhibitors in Early-stage Breast CancerA mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.
by Darcy Lewis
